Can a simple drug boost IVF success for women with repeated failures?
NCT ID NCT07185230
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 28 times
Summary
This study tests whether atosiban, a drug that relaxes the uterus, can improve live birth rates in women who have had previous embryo implantation failures and abnormal uterine contractions. About 792 women aged 20-40 will receive either atosiban or a placebo before a single embryo transfer. The goal is to see if atosiban helps more women have a successful pregnancy and live birth.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFERTILITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Center for Reproductive Medicine, Northwest Women's and Children's Hospital
RECRUITINGXi'an, Shaanxi, 710003, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.